In the last 40 years, scientists have perfected ways to determine the knot-like structures of enzymes, but they've been stumped trying to translate the structure of enzymes into an understanding of their function – what they actually do in the body.

A leading diplomat discussed called for peaceful solutions to ease tensions between the US and Iran at UCSF recently.

The health care system in California could save nearly $1.3 million a year with few adverse public health effects if it discontinued universal tuberculosis skin testing of children entering kindergarten, according to a new study by researchers at the University of California, San Francisco.

Medical genetics is revealing ever greater secrets about rare disorders that strike newborns...

In the last 40 years, scientists have perfected ways to determine the knot-like structure of enzymes, but they've been stumped trying to translate the structure into an understanding of function — what the enzyme actually does in the body. This puzzle has hurt drug discovery, since many of the most successful drugs work by blocking enzyme action. Now, in an expedited article in Nature, researchers show that a solution to the puzzle is finally in sight.

Every day, people use Google to learn more about an illness, drug or a treatment, or simply to research a condition or diagnosis.

After six to nine months of abstinence from alcohol, recovering alcoholics who were also chronic smokers showed a significantly lower rate of improvement in tests of memory, reasoning, judgment, and visual/spatial coordination than non-smoking recovering alcoholics in a study conducted by researchers at the San Francisco VA Medical Center (SFVAMC).

The University of California, San Francisco (UCSF) has finalized its first-ever campuswide strategic plan, a vision for the future with specific recommendations to guide its global leadership in health sciences.

Effective July 1, UCSF will integrate clinical services previously provided separately by the campus and medical center into a single clinical care delivery system.

Last Wednesday, President Bush issued his second veto of a bill that would have ended federal restrictions on human embryonic stem cell research. UCSF's Arnold Kriegstein, MD, PhD, director of the UCSF Institute for Regeneration Medicine, says the move puts a strain on a field that is just finding its wings.